LifeMD launches exclusive XYOSTED telehealth co-marketing program in July 2026
LifeMD announced an exclusive collaboration with Antares Pharma to offer a direct-to-patient self-pay program for XYOSTED testosterone injection, launching in 37 states at $249/month including care and medication. The partnership leverages LifeMD's virtual care platform and pharmacy to address fragmented hypogonadism treatment access.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day